Patent · US Active

Nano-delivery carrier for targeted tumor administration and application thereof

US12194004B2 · kind B2 · utility

0Cited by
0References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 29, 2024
Grant dateJan 14, 2025
Priority date
Expiry dateJul 29, 2044

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P35/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A nano-delivery carrier for targeted tumor administration and an application thereof are provided, which relate to the technical field of targeted anti-tumor dugs. A preparation method of the nano-delivery carrier for targeted tumor administration includes: mixing a NucA targeting a tumor and DSPE-PEG2000-NHS with DMF to obtain a mixture, adding triethylamine into the mixture, adjusting a pH of the mixture added with the triethylamine to 8-9 to react at room temperature, to thereby obtain the nano-delivery carrier for targeted tumor administration. An anti-tumor drug based on the nano-delivery carrier can correctly target to the tumor to be killed, for example, an anti-tumor drug based on the nano-delivery carrier and including RVT can target and kill ovarian cancer cells without damaging normal tissues.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.